What We're Reading
Industry reads hand-picked by our editors
Jul 18, 2019
Jul 17, 2019
-
The Washington Post
76 billion opioid pills: Newly released federal data unmasks the epidemic
-
Bloomberg
Newborn Screening for Rare Disease Can Be a Life-or-Death Lottery
-
MIT Technology Review
Elon Musk’s Neuralink says it’s nearly ready for the first human volunteers
-
Kaiser Health News
A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant
Jul 16, 2019
-
The New Yorker
The Promise and Price of Cellular Therapies
-
Reuters
Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end
-
Endpoints News
Takeda's translational cell therapy group revs up for a race to the clinic with off-the-shelf CAR-T
-
The Wall Street Journal
Don’t Understand Moronic Bromides (in Scientific Acronyms)?
Jul 15, 2019
-
The New York Times
Urinary Tract Infections Affect Millions. The Cures Are Faltering.
-
The Hill
Advocates frustrated over pace of drug price reform
-
Regulatory Focus
When FDA and Advisory Committees Disagree: Study Investigates Gaps
-
The New York Times
There Is No Single, Best Policy for Drug Prices
